Design and Characterization of Targeted Ultrasound Microbubbles for Diagnostic Use

2011 ◽  
Vol 37 (1) ◽  
pp. 136-150 ◽  
Author(s):  
Astrid Hilde Myrset ◽  
Hege Brincker Fjerdingstad ◽  
Ragnar Bendiksen ◽  
Bente Elisabeth Arbo ◽  
Roger Malerbakken Bjerke ◽  
...  
2010 ◽  
Vol 38 (03) ◽  
pp. 139-146 ◽  
Author(s):  
J. Richartz ◽  
N. Bauer ◽  
A. Moritz ◽  
S. Klenner

Summary Objective: In contrast to humans, neutrophil myeloperoxidase deficiency (MPOD) has been rarely investigated in dogs. The hematology analyzer ADVIA®120 differentiates leukocytes based on the cellular volume and their myeloperoxidase concentration. The aim of this study was the characterization of myeloperoxidase deficiency in dogs and the evaluation of the diagnostic use of the ADVIA®120 Myeloperoxidase Index (MPXI). Material and methods: ADVIA® peroxidase scatter plots indicative of MPOD were reviewed. Severity of MPOD was classified semiquantitatively in three groups (MPOD grade 1–3): MPOD grade 1 (MPOD-1): neutrophils showing an abnormal shift of the population, < 25% extending in the monocyte cluster and therefore misclassified, MPOD-2: ~25–50% of neutrophils misclassified, MPOD-3: 50–100% of the neutrophils misclassified due to their location in the monocyte cluster. Sex, age, and breed of the dogs as well as diagnosis, and MPXI were recorded. Results: 29 dogs (nine females and 20 males belonging to 23 breeds) with 38 analyses consistent with MPOD were found. Diseases were characterized by severe leukocyte consumption and included mainly parvovirosis (8/29), DIC/sepsis (3/29), pyometra, pyothorax, pneumonia, pancreatic abscess, and cystitis. A significantly lower mean MPXI in MPOD-3 was present in comparison to the mean MPXI of MPOD-1 (p < 0.05), however, there was a great overlap between the groups. Conclusion: Diseases associated with neutrophil consumption may show an acquired MPOD in dogs. High standard deviation limits the diagnostic use of the MPXI for detection of MPOD. Clinical relevance: The ADVIA®120 cytograms are a good screening tool for detection of MPOD in dogs, but the use of the MPXI is impaired in this species.


2021 ◽  
Vol 41 (10) ◽  
pp. 4761-4769
Author(s):  
JINDONG SUN ◽  
SHIJUN PAN ◽  
HUAMIN YU ◽  
HAIQIANG HU ◽  
YU SUN ◽  
...  

2020 ◽  
Vol 12 (5) ◽  
pp. 725-732
Author(s):  
Fangfang Yu ◽  
Jiaping Li ◽  
Yan Yang ◽  
Yueyue Cheng ◽  
Xianwei Ni ◽  
...  

By using an organic framework to fabricate functional biomaterials, novel design and advanced biomedical applications of polymeric microbubbles for in vivo targeting and disease-oriented imaging of tumor vascularization can be developed. The present study describes novel synthetic protocols to fabricate RGD (Arginine-Glycine-Aspartic)-tagged αvβ3-targeted ultrasound microbubbles. The microbubbles were synthesized by emulsion polymerization techniques. Two types of microbubbles (MBs-1 and MBs-2) were obtained via biotin-streptavidin conjugation to poly(butyl cyanoacrylate) microbubbles (MBs-0) obtained by one-step synthesis in reverse order. The size distributions and surface zeta potentials were characterized. The results showed that the sizes of the MBs-2 were larger than that those of the MBs-1, and the MBs-2 showed decreased charge compared to MBs-1. In cell targeting studies, MBs-2 exhibited relatively stronger targeting affinity for αvβ3 integrins, while MBs-1 showed weaker targeting capability. Furthermore, in vivo mice imaging using MBs-2 for intravenous injection exhibited an obvious and sustained signal increase, which revealed the accumulative of MBs-2 anchoring in tumor. Hence, MBs-2 have been proven to be a promising candidate for using as ultrasound contrast agents for the early diagnosis of αvβ3-overexpressing malignant tumors, including breast cancer.


2013 ◽  
Vol 133 (5) ◽  
pp. 3261-3261
Author(s):  
Camilo Perez ◽  
Jarred Swalwell ◽  
Juan Tu ◽  
Hong Chen ◽  
Andrew Brayman ◽  
...  

Author(s):  
Rasha Mohamed Kamal ◽  
Amr Farouk Ibrahim Moustafa ◽  
Sherihan Fakhry ◽  
Eman Faker Kamal ◽  
Amira Radwan ◽  
...  

Abstract Background Breast symmetry is one of the major things that radiologists assess when looking at mammograms and is one of the most challenging mammographic findings to evaluate. Contrast-enhanced spectral mammography (CESM) is an emerging mammography technique that has shown comparable sensitivity and specificity to MRI. The purpose of this study is to assess the value of CESM in characterization of breast asymmetries (BAs) and if it should be incorporated in its diagnostic work-up. Results Three hundred sixty-five patients with mean age of 47 years were included in the study. CESM was performed aiming for characterization of 380 suspicious or indeterminate breast asymmetries. Assessment of subtracted high-energy images (HEI) markedly improves the overall accuracy reaching 88.4%. Further improvement of the overall accuracy was achieved on combined assessment of the low-energy images (LEI), subtracted high-energy images (HEI), and ultrasound reaching 91.3%. Conclusion CESM is considered as a valuable complementary imaging tool considering the evaluation of breast asymmetries and should be incorporated in its diagnostic work-up in cases not resolved on an initial combined mammography and targeted ultrasound study especially in the presence of a heterogeneous dense breast parenchyma. Yet, this may be hindered in the presence of inflammatory signs because of the overlapping imaging criteria.


PLoS ONE ◽  
2017 ◽  
Vol 12 (5) ◽  
pp. e0176958 ◽  
Author(s):  
Aimen Zlitni ◽  
Melissa Yin ◽  
Nancy Janzen ◽  
Samit Chatterjee ◽  
Ala Lisok ◽  
...  

2003 ◽  
Vol 89 (2) ◽  
pp. 372-378 ◽  
Author(s):  
Ada I. Zurita ◽  
Javier Rodríguez ◽  
José E. Piñero ◽  
Rosa Pacheco ◽  
Emma Carmelo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document